Cargando…
Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b
Clinical outcomes of patients with multiple myeloma (MM) have almost doubled the overall survival over the last decade owing to the use of proteasome inhibitor such as bortezomib (BTZ). However, some patients with MM develop primary resistance to BTZ, whereas others develop resistance after treatmen...
Autores principales: | Fu, Yunfeng, Liu, Xiao, Zhang, Fangrong, Jiang, Siyi, Liu, Jing, Luo, Yanwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456577/ https://www.ncbi.nlm.nih.gov/pubmed/30967527 http://dx.doi.org/10.1038/s41419-019-1551-z |
Ejemplares similares
-
MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment
por: Gu, Chunyan, et al.
Publicado: (2015) -
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
por: Amodio, N, et al.
Publicado: (2012) -
PHLPP Sensitizes Multiple Myeloma Cells to Bortezomib Through Regulating LAMP2
por: Liu, Xiao, et al.
Publicado: (2020) -
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma
por: Amodio, Nicola, et al.
Publicado: (2019) -
Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma
por: Luo, Yanwei, et al.
Publicado: (2020)